All In Biotech

Drug Trial Radar · NCT07546760

A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234

A Phase I, Multicentre, Single-Dose, Non-Randomised, Open-Label, Parallel-Group Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD9550 and AZD6234

Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

28

Planned (sponsor's estimate)

Start

Mar 20, 2026

Primary completion

Feb 4, 2027

Study completion Feb 4, 2027

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Apr 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to examine the safety and tolerability of AZD6234 and AZD9550 in participants with hepatic impairment and participants with normal hepatic function.

Conditions

  • Hepatic Impairment

Interventions

  • AZD6234Drug

    Single subcutaneous dose of AZD6234 in participants from all groups

  • AZD9550Drug

    Single subcutaneous dose of AZD9550 in participants from all groups

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. PK parameters AUCinfTime frame: Day 0 through Day 56
  2. PK parameters AUClastTime frame: Day 0 through Day 56
  3. PK parameters CmaxTime frame: Day 0 through Day 56

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Chandler, Arizona · Recruiting

  • Research Site

    Rialto, California · Terminated

  • Research Site

    Miami Lakes, Florida · Recruiting

  • Research Site

    San Antonio, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.